CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 1.810
+0.035 (1.97%)
Jun 17, 2026, 4:24 PM GMT
CelLBxHealth Market Cap
CelLBxHealth has a market cap or net worth of 20.17 million as of June 17, 2026. Its market cap has decreased by -21.82% in one year.
Market Cap
20.17M
Enterprise Value
18.57M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.81
Market Cap Chart
Since August 16, 2004, CelLBxHealth's market cap has decreased from 20.37M to 20.17M, a decrease of -0.97%. That is a compound annual growth rate of -0.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 20.17M | 61.36% |
| Dec 31, 2025 | 12.50M | -62.19% |
| Dec 31, 2024 | 33.06M | 8.02% |
| Dec 29, 2023 | 30.60M | -76.73% |
| Dec 30, 2022 | 131.54M | -52.97% |
| Dec 31, 2021 | 279.69M | 172.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.80B |
| GSK plc | 79.20B |
| Haleon | 29.84B |
| Smith & Nephew | 9.61B |
| Arecor Therapeutics | 23.60M |
| Inspiration Healthcare Group | 23.31M |
| Provexis | 22.05M |
| SkinBioTherapeutics | 22.03M |